Oral 5-ASA Versus Prednisone in Short Term Treatment of Crohn's Disease: A Multicentre Controlled Trial
A multicencre randomized controlled trial was designed to compare the efficacy and safety of Eudragit-L coated oral 5-aminosalicylic acid (5-ASA) (Salofalk; lnterfalk) 3 g per day to a 'standard' oral prednisone therapeutic regimen in a 12 week treatment period of uncomplicated attacks of...
Saved in:
| Main Authors: | F Martin, L Sutherland, IT Beck, AH Anderson, CN Williams, F Saibel, J Barrowman, S Lemire |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1990-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1990/659079 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenous methylprednisolone versus oral prednisone for initial attacks of optic neuritis, A review of evidence
by: Teresita R. Castillo, MD, MHPEd
Published: (2005-06-01) -
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study
by: Frank Buttgereit, et al.
Published: (2019-06-01) -
5-ASA Therapy in Solitary Rectal Ulcer Syndrome. Report of Three Patients
by: D.A. Malatjalian, et al.
Published: (1988-01-01) -
Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)
by: Burkhard Toenshoff, et al.
Published: (2018-10-01) -
Carbamazepine Rash and Prednisone
by: J Gordon Millichap
Published: (1991-02-01)